Increased expression of these immune checkpoint receptors in CD4+ and CD8+ T cells of HNSCC tumor bearing Stat4−/− mice demonstrate the requirement for STAT4 in the inhibition of immunosuppressive T cell pathways and initiation of an appropriate immune response against metastatic HNSCC. This evidence concerns the gene CD8A and head and neck squamous cell carcinoma.